Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis

Measuring inconsistency in meta-analyses

Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works

Bias in meta-analysis detected by a simple, graphical test

Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works

Meta-analysis in clinical trials

DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works

Quantifying heterogeneity in a meta‐analysis

Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · see citing works

The “Golden Age” of Probiotics: A Systematic Review and Meta-Analysis of Randomized and Observational Studies in Preterm Infants

Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,577 · see citing works

Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>

Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623 · see citing works

Conducting Meta-Analyses in <i>R</i> with the <b>metafor</b> Package

Viechtbauer, W. (2010) · Journal of Statistical Software · doi:10.18637/jss.v036.i03 · Cited by 20,464 · see citing works

Untitled work

(2014) · Medical Entomology and Zoology · Cited by 17,633 · see citing works

Publication bias in clinical research

Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109 · see citing works

Burden of Gastrointestinal Disease in the United States: 2012 Update

Peery, A. F., Dellon, E. S., Lund, J. L., Crockett, S. D., McGowan, C., Bulsiewicz, W. J., Gangarosa, L. M., Thiny, M. T., Stizenberg, K., Morgan, D. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.002 · Cited by 2,010 · see citing works

A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality

Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M., Michaud, S., Bourgault, A., Nguyen, T. T., Frenette, C. H., Kelly, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051639 · Cited by 1,944 · see citing works

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

Surawicz, C. M., Brandt, L. J., Binion, D. G., Ananthakrishnan, A. N., Curry, S. R., Gilligan, P. H., McFarland, L. V., Mellow, M., & Zuckerbraun, B. S. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.4 · Cited by 1,645 · see citing works

Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in Quebec

Pépin, J., Saheb, N., Coulombe, M., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995 · see citing works

Use of Gastric Acid–Suppressive Agents and the Risk of Community-Acquired Clostridium difficile –Associated Disease

Dial, S. (2005) · JAMA · doi:10.1001/jama.294.23.2989 · Cited by 954 · see citing works

Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile

Kyne, L., Hamel, M. B., Polavaram, R., & Kelly, C. P. (2002) · Clinical Infectious Diseases · doi:10.1086/338260 · Cited by 902 · see citing works

The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association

Freedberg, D. E., Kim, L. S., & Yang, Y. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 896 · see citing works

Host and Pathogen Factors for Clostridium difficile Infection and Colonization

Loo, V. G., Bourgault, A., Poirier, L., Lamothe, F., Michaud, S., Turgeon, N., Toye, B., Beaudoin, A., Frost, E. H., Gilca, R., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012413 · Cited by 791 · see citing works

The Burden of Gastrointestinal and Liver Diseases, 2006

Shaheen, N. J., Hansen, R. A., Morgan, D. R., Gangarosa, L. M., Ringel, Y., Thiny, M. T., Russo, M. W., & Sandler, R. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00723.x · Cited by 694 · see citing works

Systematic review of the risk of enteric infection in patients taking acid suppression

Leonard, J., Marshall, J. K., & Moayyedi, P. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01275.x · Cited by 633 · see citing works

A Large Outbreak ofClostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use

Muto, C. A., Pokrywka, M., Shutt, K. A., Mendelsohn, A. B., Nouri, K., Posey, K., Roberts, T. L., Croyle, K. S., Krystoflak, S., Patel-Brown, S., et al. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502539 · Cited by 619 · see citing works

Risk of Clostridium difficile Infection With Acid Suppressing Drugs and Antibiotics: Meta-Analysis

Kwok, C. S., Arthur, A. K., Anibueze, C. I., Singh, S., Cavallazzi, R., & Loke, Y. K. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.108 · Cited by 579 · see citing works

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

Dial, S. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040876 · Cited by 577 · see citing works

Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis

Janarthanan, S., Ditah, I., Adler, D. G., & Ehrinpreis, M. N. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.179 · Cited by 538 · see citing works

Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection

Bavishi, C., & DuPont, H. L. (2011) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/j.1365-2036.2011.04874.x · Cited by 480 · see citing works

Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression

for the SIF-AIGO-FIMMG Group, Scarpignato, C., on behalf of the Italian Society of Pharmacology, T. I. A. O. H. G., Gatta, L., Zullo, A., & Blandizzi, C. (2016) · BMC Medicine · doi:10.1186/s12916-016-0718-z · Cited by 469 · see citing works

Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection

Howell, M. D. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.89 · Cited by 436 · see citing works

Epidemiology of Community-AssociatedClostridium difficileInfection, 2009 Through 2011

Chitnis, A. S., Holzbauer, S., Belflower, R., Winston, L. G., Bamberg, W., Lyons, C., Farley, M. M., Dumyati, G. K., Wilson, L. E., Beldavs, Z. G., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.7056 · Cited by 403 · see citing works

Clostridium difficile infection: epidemiology, risk factors and management

Ananthakrishnan, A. N. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.190 · Cited by 353 · see citing works

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study.

Thorens, J.-J., Froehlich, F., Schwizer, W., Saraga, E. P., Billé, J., Gyr, K. E., Duroux, P., Nicolet, M., Pignatelli, B., Blum, A. L., et al. (1996) · Gut · doi:10.1136/gut.39.1.54 · Cited by 339 · see citing works

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population

Shah, N. H., LePendu, P., Bauer‐Mehren, A., Ghebremariam, Y. T., Iyer, S. V., Marcus, J. R., Nead, K. T., Cooke, J. P., & Leeper, N. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124653 · Cited by 332 · see citing works

Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea

Cunningham, R., Dale, B., Undy, B., & Gaunt, N. (2003) · Journal of Hospital Infection · doi:10.1016/s0195-6701(03)00088-4 · Cited by 331 · see citing works

Risk of Community-Acquired Pneumonia with Outpatient Proton-Pump Inhibitor Therapy: A Systematic Review and Meta-Analysis

Lambert, A., Lam, J. O., Paik, J. J., Ugarte‐Gil, C., Drummond, M., & Crowell, T. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128004 · Cited by 327 · see citing works

Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review

Thomas, C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg254 · Cited by 302 · see citing works

Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients

Alhazzani, W. A., Alenezi, F. Z., Jaeschke, R. Z., Moayyedi, P., & Cook, D. J. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182758734 · Cited by 259 · see citing works

Epidemiology of Clostridium difficile Infection

DePestel, D. D., & Aronoff, D. M. (2013) · Journal of Pharmacy Practice · doi:10.1177/0897190013499521 · Cited by 244 · see citing works

C. difficile Infection: Changing Epidemiology and Management Paradigms

Vindigni, S. M., & Surawicz, C. M. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.24 · Cited by 236 · see citing works

Gastric Acid Suppression by Proton Pump Inhibitors as a Risk Factor for Clostridium Difficile -Associated Diarrhea in Hospitalized Patients

Aseeri, M. A., Schroeder, T., Kramer, J., & Zackula, R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01975.x · Cited by 236 · see citing works

The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis

Moayyedi, P., Delaney, B. C., Vakil, N. B., Forman, D., & Talley, N. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.026 · Cited by 230 · see citing works

Risk Factors for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-Analysis

Deshpande, A., Pasupuleti, V., Thota, P., Pant, C., Rolston, D. D. K., Hernández, A. V., Donskey, C. J., & Fraser, T. G. (2015) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2014.88 · Cited by 221 · see citing works

Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections

Schneeweiß, S., Korzenik, J. R., Solomon, D. H., Canning, C. F., Lee, J. L.-Y., & Bressler, B. L. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04037.x · Cited by 216 · see citing works

Proton pump inhibitor use and risk of community-acquired Clostridium difficile-associated disease defined by prescription for oral vancomycin therapy

Dial, S. (2006) · Canadian Medical Association Journal · doi:10.1503/cmaj.060284 · Cited by 216 · see citing works

Safety of Proton Pump Inhibitor Exposure

Yang, Y., & Metz, D. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.08.023 · Cited by 215 · see citing works

Association Between Proton Pump Inhibitor Therapy and Clostridium difficile Infection in a Meta-Analysis

Deshpande, A., Pant, C., Pasupuleti, V., Rolston, D. D. K., Jain, A., Deshpande, N., Thota, P., Sferra, T. J., & Hernández, A. V. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.09.030 · Cited by 211 · see citing works

Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity*

Zedtwitz‐Liebenstein, K., Wenisch, C., Patruta, S., Parschalk, B., Daxböck, F., & Graninger, W. (2002) · Critical Care Medicine · doi:10.1097/00003246-200205000-00026 · Cited by 207 · see citing works

Risk Factors for and Estimated Incidence of Community-associatedClostridium difficileInfection, North Carolina, USA1

Kutty, P. K., Woods, C. W., Seña, A. C., Benoit, S. R., Naggie, S., Frederick, J., Evans, S., Engel, J., & McDonald, L. C. (2010) · Emerging infectious diseases · doi:10.3201/eid1602.090953 · Cited by 206 · see citing works

Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites

Dam, G., Vilstrup, H., Watson, H., & Jepsen, P. (2016) · Hepatology · doi:10.1002/hep.28737 · Cited by 190 · see citing works

Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications

Heidelbaugh, J. J. (2013) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098613482484 · Cited by 189 · see citing works

Gastric microbiota is altered in oesophagitis and <scp>B</scp> arrett's oesophagus and further modified by proton pump inhibitors

Amir, I., Konikoff, F. M., Oppenheim, M., Gophna, U., & Half, E. E. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12285 · Cited by 176 · see citing works

Clostridium difficile Is Associated With Poor Outcomes in Patients With Cirrhosis: A National and Tertiary Center Perspective

Bajaj, J. S., Ananthakrishnan, A. N., Hafeezullah, M., Zadvornova, Y., Dye, A., McGinley, E. L., Saeian, K., Heuman, D. M., Sanyal, A. J., & Hoffmann, R. G. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.615 · Cited by 174 · see citing works

Clinical Trials Report

Coyle, W. (2006) · Current Gastroenterology Reports · doi:10.1007/s11894-006-0050-4 · Cited by 171 · see citing works

Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection

Dial, S., Kezouh, A., Dascal, A., Barkun, A. N., & Suissa, S. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071812 · Cited by 166 · see citing works

Overutilization of Proton Pump Inhibitors: A Review of Cost-Effectiveness and Risk in PPI

Heidelbaugh, J. J., Goldberg, K. L., & Inadomi, J. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.49 · Cited by 165 · see citing works

Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility

Seto, C. T., Jeraldo, P., Orenstein, R., Chia, N., & DiBaise, J. K. (2014) · Microbiome · doi:10.1186/2049-2618-2-42 · Cited by 163 · see citing works

Proton Pump Inhibitors vs. Histamine 2 Receptor Antagonists for Stress-Related Mucosal Bleeding Prophylaxis in Critically Ill Patients: A Meta-Analysis

Barkun, A. N., Bardou, M., Pham, C. Q. D., & Martel, M. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.474 · Cited by 162 · see citing works

Systematic review: proton pump inhibitor‐associated acute interstitial nephritis

Sierra, F., SUAREZ, M., Rey, M., et al. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03407.x · Cited by 161 · see citing works

Incidence of and risk factors for community-associated Clostridium difficile infection: A nested case-control study

Kuntz, J. L., Chrischilles, E. A., Pendergast, J., Herwaldt, L. A., & Polgreen, P. M. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-194 · Cited by 161 · see citing works

The growing incidence and severity ofClostridium difficileinfection in inpatient and outpatient settings

Khanna, S., & Pardi, D. S. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.48 · Cited by 159 · see citing works

Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks

Rostom, A., Moayyedi, P., & Hunt, R. H. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03905.x · Cited by 157 · see citing works

Proton Pump Inhibitors and Hospitalization for Clostridium Difficile--Associated Disease: A Population-Based Study

Lowe, D. O., Mamdani, M. M., Kopp, A., Low, D. E., & Juurlink, D. N. (2006) · Clinical Infectious Diseases · doi:10.1086/508453 · Cited by 155 · see citing works

Update on the changing epidemiology of Clostridium difficile-associated disease

McFarland, L. V. (2008) · Nature Clinical Practice Gastroenterology &#38 Hepatology · doi:10.1038/ncpgasthep1029 · Cited by 153 · see citing works

Case-Control Study of Antibiotic Use and Subsequent Clostridium difficile–Associated Diarrhea in Hospitalized Patients

Baxter, R. P., Ray, G. T., & Fireman, B. H. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/524320 · Cited by 151 · see citing works

Association between Proton Pump Inhibitor Therapy and Clostridium difficile Infection: A Contemporary Systematic Review and Meta-Analysis

Tleyjeh, I. M., Abdulhak, A. A. B., Riaz, M. A., Alasmari, F. A., Garbati, M. A., Alghamdi, M. A. A., Khan, A. R., Al-Tannir, M. A., Erwin, P. J., Ibrahim, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050836 · Cited by 148 · see citing works

The rise in Clostridium difficile infection incidence among hospitalized adults in the United States: 2001-2010

Reveles, K. R., Lee, G. C., Boyd, N. K., & Frei, C. R. (2014) · American Journal of Infection Control · doi:10.1016/j.ajic.2014.06.011 · Cited by 145 · see citing works

Proton pump inhibitor therapy is a risk factor for Clostridium difficile ‐associated diarrhoea

YEARSLEY, K. A., GILBY, L. J., Ramadas, A., Kubiak, E., Fone, D. L., & Allison, M. C. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03015.x · Cited by 145 · see citing works

Who is using chronic acid suppression therapy and why?

Jacobson, B. C., Ferris, T. G. G., Shea, T. L., Mahlis, E. M., Lee, T. H.-Y., & Wang, T. C. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07186.x · Cited by 143 · see citing works

Long‐term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies

Attwood, S., Ell, C., Galmiche, J. P., Fiocca, R., Hatlebakk, J. G., Hasselgren, B., Långström, G., Jahreskog, M., Eklund, S., Lind, T., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13194 · Cited by 141 · see citing works

Evaluation of Clostridium difficile–Associated Disease Pressure as a Risk Factor for C difficile–Associated Disease

Dubberke, E. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.10.1092 · Cited by 141 · see citing works

Clostridium difficile in the Intensive Care Unit: Epidemiology, Costs, and Colonization Pressure

Lawrence, S. J., Puzniak, L., Shadel, B. N., et al. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/511793 · Cited by 139 · see citing works

Proton pump inhibitors are associated with increased risk of development of chronic kidney disease

Arora, P., Gupta, A., Golzy, M., et al. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0325-4 · Cited by 126 · see citing works

Use of Acid-Suppressive Drugs and Risk of Fracture: A Meta-analysis of Observational Studies

Eom, C.-S., Park, S.-M., Myung, S., et al. (2011) · The Annals of Family Medicine · doi:10.1370/afm.1243 · Cited by 122 · see citing works

A Hospital Outbreak of Diarrhea Due to an Emerging Epidemic Strain of Clostridium difficile

Kazakova, S. V. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2518 · Cited by 117 · see citing works

Albumin, Length of Stay, and Proton Pump Inhibitors

Al-Tureihi, F. I. J., Hassoun, A., Wolf‐Klein, G. P., & Isenberg, H. D. (2005) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2005.01.003 · Cited by 116 · see citing works

Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile–associated diarrhea

Buendgens, L., Bruensing, J., Matthes, M., Dückers, H., Luedde, T., Trautwein, C., Tacke, F., & Koch, A. H. (2014) · Journal of Critical Care · doi:10.1016/j.jcrc.2014.03.002 · Cited by 113 · see citing works

Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients

Freedberg, D. E., Salmasian, H., Friedman, C., & Abrams, J. A. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.333 · Cited by 112 · see citing works

Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people.

Husebye, E., Skar, V., Høverstad, T., & Melby, K. K. (1992) · Gut · doi:10.1136/gut.33.10.1331 · Cited by 108 · see citing works

Quinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated Diarrhea

Yip, C., Loeb, M. B., Salama, S. E., Moss, L., & Olde, J. (2001) · Infection Control and Hospital Epidemiology · doi:10.1086/501954 · Cited by 105 · see citing works

Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease

Choudhry, M., Soran, H., & Ziglam, H. M. (2008) · QJM · doi:10.1093/qjmed/hcn035 · Cited by 99 · see citing works

Clostridium difficile Colonization in Residents of Long‐Term Care Facilities: Prevalence and Risk Factors

Walker, K. J., Gilliland, S. S., Vance‐Bryan, K., Moody, J. A., Larsson, A. J., Rotschafer, J. C., & Guay, D. R. P. (1993) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1993.tb06759.x · Cited by 97 · see citing works

A Case-control Study of Community-associated Clostridium difficile Infection: No Role for Proton Pump Inhibitors

Naggie, S., Miller, B. A., Zuzak, K. B., Pence, B. W., Mayo, A., Nicholson, B. P., Kutty, P. K., McDonald, L. C., & Woods, C. W. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.10.013 · Cited by 96 · see citing works

Prevalence and Symptom Pattern of Pathologic Esophageal Acid Reflux in Patients With Functional Dyspepsia Based on the Rome III Criteria

Xiao, Y., Peng, S., Tao, J., Wang, A., Lin, J.-K., Hu, P., & Chen, M. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.351 · Cited by 95 · see citing works

Proton pump inhibitors increase significantly the risk ofClostridium difficileinfection in a low‐endemicity, non‐outbreak hospital setting

Dalton, B., LYE‐MACCANNELL, T., Henderson, E. A., MacCannell, D., & Louie, T. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03924.x · Cited by 94 · see citing works

Multicenter Study of Clostridium difficile Infection Rates from 2000 to 2006

Dubberke, E. R., Butler, A. M., Yokoe, D. S., Mayer, J., Hota, B. N., Mangino, J. E., Khan, Y. M., Popovich, K. J., & Fraser, V. J. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/656245 · Cited by 92 · see citing works

Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis

Xu, H., Wang, H. D., Li, C., Ye, S., Dong, M. S., Xia, Q. J., Zhang, A. Q., Pan, K., Ge, X., & Dong, J. (2015) · Genetics and Molecular Research · doi:10.4238/2015.july.3.25 · Cited by 88 · see citing works

Gastric acid suppression does not promote clostridial diarrhoea in the elderly

Shah, S. (2000) · QJM · doi:10.1093/qjmed/93.3.175 · Cited by 88 · see citing works

Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients

Barletta, J. F., & Sclar, D. A. (2014) · Critical Care · doi:10.1186/s13054-014-0714-7 · Cited by 87 · see citing works

Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review

Gabriel, L. E. K., & Beriot‐Mathiot, A. (2014) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.04.011 · Cited by 86 · see citing works

Recurrent Community-acquired Pneumonia in Patients Starting Acid-suppressing Drugs

Eurich, D. T., Sadowski, C. A., Simpson, S. H., Marrie, T. J., & Majumdar, S. R. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.05.032 · Cited by 83 · see citing works

The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study

Kelly, O., Dillane, C., Patchett, S. E., Harewood, G. C., & Murray, F. E. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3642-8 · Cited by 80 · see citing works

Assessing the Risk of Hospital-AcquiredClostridium DifficileInfection With Proton Pump Inhibitor Use: A Meta-Analysis

Arriola, V., Tischendorf, J. S., Musuuza, J., Barker, A., Rozelle, J. W., & Safdar, N. (2016) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2016.194 · Cited by 77 · see citing works

Long‐term, open‐label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid‐peptic disease

Brunner, G. H. G., Athmann, C., & Schneider, A. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05106.x · Cited by 76 · see citing works

Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors

Debast, S. B., Vaessen, N., Choudry, A., Wiegers-Ligtvoet, E. A. J., van den Berg, R. J., & Kuijper, E. J. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02713.x · Cited by 71 · see citing works

Potential Costs of Inappropriate Use of Proton Pump Inhibitors

Ladd, A. M., Panagopoulos, G., Cohen, J., Mar, N., & Graham, R. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31829f87d5 · Cited by 68 · see citing works

Clostridium difficile Among Hospitalized Patients Receiving Antibiotics A Case-Control Study

Modena, S., Bearelly, D., Swartz, K., & Friedenberg, F. K. (2005) · Infection Control and Hospital Epidemiology · doi:10.1086/502603 · Cited by 67 · see citing works

Risk factors for Clostridium difficile toxin-positive diarrhea: a population-based prospective case–control study

VESTEINSDOTTIR, I. O., Guðlaugsdóttir, S., Einarsdóttir, R., Kalaitzakis, E., Sigurðardóttir, Ó., & Bjornsson, E. S. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1603-0 · Cited by 66 · see citing works

Clostridium difficile infection in an urban medical center: five-year analysis of infection rates among adult admissions and association with the use of proton pump inhibitors.

Jayatilaka, S. G., Shakov, R., Eddi, R., Bakaj, G., Baddoura, W., & DeBari, V. A. (2007) · PubMed · Cited by 65 · see citing works

Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea?

Cunningham, R., & Dial, S. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.04.023 · Cited by 63 · see citing works

Proton pump inhibitors and risk of dementia

Wijarnpreecha, K., Thongprayoon, C., Panjawatanan, P., & Ungprasert, P. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.06.14 · Cited by 60 · see citing works

Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit

Faleck, D. M., Salmasian, H., Furuya, Y. E., Larson, E., Abrams, J. A., & Freedberg, D. E. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.343 · Cited by 60 · see citing works

Chronic kidney disease as a risk factor for Clostridium difficile infection

Eddi, R., MALIK, M. N., Shakov, R., et al. (2010) · Nephrology · doi:10.1111/j.1440-1797.2009.01274.x · Cited by 59 · see citing works

Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control

Marwick, C., Yu, N., Lockhart, M., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt257 · Cited by 58 · see citing works

The changing epidemiology of Clostridium difficile infection

Honda, H., & Dubberke, E. R. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000018 · Cited by 54 · see citing works

Risk of Clostridium difficile -Associated Disease Among Patients Receiving Proton-Pump Inhibitors in a Quebec Medical Intensive Care Unit

Beaulieu, M., Williamson, D. R., Pichette, G., & Lachaîne, J. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/521664 · Cited by 54 · see citing works

Prevalence and management of antibiotic associated diarrhea in general hospitals

Elseviers, M. M., Camp, Y. P. M. V., Nayaert, S., Duré, K., Annemans, L., Tanghe, A., & Vermeersch, S. J. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0869-0 · Cited by 53 · see citing works

Predicting Clostridium difficile Toxin in Hospitalized Patients With Antibiotic-Associated Diarrhea

Peled, N., Pitlik, S. D., Samra, Z., et al. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/513723 · Cited by 52 · see citing works

Proton Pump Inhibitors and Risk of Bone Fractures

Leontiadis, G. I., & Moayyedi, P. (2014) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-014-0030-y · Cited by 52 · see citing works

Clostridium difficile infection in an endemic setting in the Netherlands

Hensgens, M. P. M., Goorhuis, A., van Kinschot, C. M. J., Crobach, M. J. T., Harmanus, C., & Kuijper, E. J. (2010) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-010-1127-4 · Cited by 50 · see citing works

Prevalence and clinical course of Clostridium difficile infection in a tertiary-care hospital: a retrospective analysis

Ingle, M., Deshmukh, A. M., Desai, D., Abraham, P., Joshi, A. G., Rodrigues, C. S., & Mankeshwar, R. (2011) · Indian Journal of Gastroenterology · doi:10.1007/s12664-011-0097-5 · Cited by 50 · see citing works

Medical and non‐medical predictors of initiating long‐term use of proton pump inhibitors: a nationwide cohort study of first‐time users during a 10‐year period

Haastrup, P., Paulsen, M. S., Christensen, R. D., Søndergaard, J., Hansen, J. M., & Jarbøl, D. E. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13649 · Cited by 50 · see citing works

Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study

Haroon, M. Z., Yasin, F., Gardezi, S. K. M., Adeeb, F., & Walker, F. (2013) · JRSM Short Reports · doi:10.1177/2042533313497183 · Cited by 49 · see citing works

Risk factors associated with Clostridium difficile infection in adult oncology patients

Garzotto, A. A. R., Garcia, A., Unceta, N. M., Lopez, M. M. G., Orellana, M. Á., Díaz-García, C. V., Cortijo‐Cascajares, S., Cortés-Funes, H., & Agulló-Ortuño, M. T. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2506-7 · Cited by 49 · see citing works

Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors

CRAIG, D. G. N., Thimappa, R., Anand, V., et al. (2010) · QJM · doi:10.1093/qjmed/hcq019 · Cited by 48 · see citing works

Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres

Pakyz, A. L., Jawahar, R., Wang, Q., & Harpe, S. E. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt489 · Cited by 47 · see citing works

Postoperative Clostridium difficile-associated diarrhea

Southern, W. N., Rahmani, R., Aroniadis, O. C., Khorshidi, I., Thanjan, A., Ibrahim, C. B., & Brandt, L. J. (2010) · Surgery · doi:10.1016/j.surg.2009.11.021 · Cited by 46 · see citing works

Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis

Roughead, E. E., Chan, E. W., Choi, N., et al. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1238071 · Cited by 42 · see citing works

Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients

Ro, Y., Eun, C. S., Kim, H. S., et al. (2016) · Gut and Liver · doi:10.5009/gnl15324 · Cited by 41 · see citing works

Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis

Dubberke, E. R., Olsen, M. A. A., Stwalley, D. L., Kelly, C. P., Gerding, D. N., Young‐Xu, Y., & Mahé, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146822 · Cited by 38 · see citing works

Clostridium Difficile Infection Following Chemotherapy

Raza, S., Baig, M. A., Russell, H., et al. (2009) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489110790112608 · Cited by 37 · see citing works

Proton Pump Inhibitor Formulary Considerations in the Acutely Ill Part 2: Clinical Efficacy, Safety, and Economics

Devlin, J. W., Welage, L. S., & Olsen, K. M. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g176 · Cited by 37 · see citing works

Iron-deficiency Anemia Caused by a Proton Pump Inhibitor

Hashimoto, R., Matsuda, T., & Chonan, A. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.2743 · Cited by 36 · see citing works

Predictors ofClostridium difficileinfection severity in patients hospitalised in medical intensive care

Khanafer, N. L. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i44.8034 · Cited by 36 · see citing works

Burden ofClostridium difficileinfection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe

Kürti, Z. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i21.6728 · Cited by 36 · see citing works

Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital

Morfín‐Otero, R., Garza‐González, E., Aguirre-Díaz, S. A., Escobedo-Sánchez, R., Esparza-Ahumada, S., Pérez-Gómez, H. R., Petersen-Morfín, S., González-Díaz, E., Martínez-Meléndez, A., & Rodríguez-Noriega, E. (2015) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2015.09.008 · Cited by 35 · see citing works

Incidence and risk factors for hospital-acquired Clostridium difficile infection among inpatients in an orthopaedic tertiary care hospital

Campbell, K. A., Phillips, M., Stachel, A. G., et al. (2013) · Journal of Hospital Infection · doi:10.1016/j.jhin.2012.11.009 · Cited by 34 · see citing works

Appropriateness of gastric antisecretory therapy in hospital practice

Sebastian, S., Kernan, N. A., Qasim, A., et al. (2003) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf02914494 · Cited by 33 · see citing works

Proton pump inhibitors induce changes in colonocyte gene expression that may affect Clostridium difficile infection

Hegarty, J. P., Sangster, W., Harris, L., et al. (2014) · Surgery · doi:10.1016/j.surg.2014.06.074 · Cited by 32 · see citing works

Increasing incidence of clostridium difficile-associated diarrhea in African-American and Hispanic patients: association with the use of proton pump inhibitor therapy.

Akhtar, A. J., & Shaheen, M. A. (2007) · PubMed · Cited by 31 · see citing works

PPI Therapy and Albumin are Better Predictors of Recurrent Clostridium difficile Colitis than Choice of Antibiotics

Rotramel, A. R., Poritz, L. S., Messaris, E., Berg, A. S., & Stewart, D. B. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2037-9 · Cited by 31 · see citing works

Proton Pump Inhibitors for Prophylaxis of Nosocomial Upper Gastrointestinal Tract Bleeding

Yachimski, P. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.51 · Cited by 30 · see citing works

Does PPI therapy predispose to Clostridium difficile infection?

Pant, C., Madonia, P. N., & Minocha, A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.128 · Cited by 28 · see citing works

Risks factors and outcomes of Clostridium difficile infection in patients with cancer: a matched case-control study

Hebbard, A. I. T., Slavin, M. A., Reed, C., et al. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-017-3606-y · Cited by 27 · see citing works

Defining Appropriate Use of Proton-Pump Inhibitors Among Medical Inpatients

Pappas, M. A., Jolly, S., & Vijan, S. S. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3536-7 · Cited by 26 · see citing works

Clinical characteristics and risk factors for community-acquired Clostridium difficile infection: A retrospective, case-control study in a tertiary care hospital in Japan

Mori, N., & Aoki, Y. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.09.004 · Cited by 24 · see citing works

Clostridium difficile as a cause of acute diarrhea: a prospective study in a tertiary care center

Ingle, M., Deshmukh, A., Desai, D., Abraham, P., Joshi, A. G., Gupta, T., & Rodrigues, C. S. (2013) · Indian Journal of Gastroenterology · doi:10.1007/s12664-013-0303-8 · Cited by 23 · see citing works

Risk and Severity of Hospital‐Acquired Clostridium difficile Infection in Patients Taking Proton Pump Inhibitors

Lewis, P. O., Litchfield, J., Tharp, J. L., Garcia, R. M., Pourmorteza, M., & Reddy, C. M. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1801 · Cited by 22 · see citing works

Potential Cardiovascular Risks of Proton Pump Inhibitors in the General Population

Zhu, W., & Hong, K. (2017) · International Heart Journal · doi:10.1536/ihj.16-208 · Cited by 20 · see citing works

Acid-suppressive medications and risk of fracture: an updated meta-analysis.

Cai, D., Feng, W., & Jiang, Q. Y. (2015) · PubMed · Cited by 18 · see citing works

Epidemiological features of Clostridium difficile infection among inpatients at Hamad General Hospital in the state of Qatar, 2006–2009

Khan, F. Y., Abukhattab, M., Deshmukh, A., et al. (2012) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2012.06.004 · Cited by 15 · see citing works

Sources of heterogeneity in case–control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia

de Groot, M., Klungel, O. H., Leufkens, H. G. M., van Dijk, L., Grobbee, D. E., & van de Garde, E. M. W. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9941-0 · Cited by 14 · see citing works

Proton Pump Inhibitors and Clostridium Difficile Infection: Are We Propagating an Already Rapidly Growing Healthcare Problem?

Patil, P. (2013) · Gastroenterology Research · doi:10.4021/gr575w · Cited by 13 · see citing works

Clostridium difficile infection in the elderly.

Taslim, H. (2009) · PubMed · Cited by 13 · see citing works

Proton Pump Inhibitor Use and Clostridium difficile Colitis

McCarthy, D. M. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31824b228f · Cited by 13 · see citing works

Prophylaxis for Stress Ulcers With Proton Pump Inhibitors Is Not Associated With Increased Risk of Bloodstream Infections in the Intensive Care Unit

Cohen, M. E., Hathway, J. M., Salmasian, H., Liu, J., Terry, M., Abrams, J. A., & Freedberg, D. E. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.12.035 · Cited by 13 · see citing works

Association Between Use of Proton Pump Inhibitors and a Clostridium difficile– Associated Disease Outbreak: Case–Control Study

Linney, S., Fernandes, T., Einarson, T. R., Sengar, A., Walker, J. H., & Mills, A. (2010) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v63i1.866 · Cited by 11 · see citing works

Risk factors for Clostridium difficile-associated diarrhea and the effectiveness of prophylactic probiotic therapy

Mizui, T., Teramachi, H., Tachi, T., et al. (2013) · Die Pharmazie · doi:10.31083/ph.2013.3552 · Cited by 10 · see citing works

Inappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with Clostridium difficile—Associated Diarrhea: A Ten-Year Retrospective Analysis

Rashid, S., Rajan, D., Iqbal, J., et al. (2012) · ISRN Gastroenterology · doi:10.5402/2012/902320 · Cited by 10 · see citing works

The Simple Predictors of Pseudomembranous Colitis in Patients with Hospital-Acquired Diarrhea: A Prospective Observational Study

Yang, B. K., Ju, B., Kim, E., et al. (2014) · Gut and Liver · doi:10.5009/gnl.2014.8.1.41 · Cited by 8 · see citing works

Characteristics of patients withClostridium difficileinfection in Taiwan

LIN, Y.-C., Huang, Y., LEE, T.-F., Lee, N.-Y., Liao, C., Lin, S.-Y., Ko, W., & Hsueh, P. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812002749 · Cited by 7 · see citing works

PPIs and Chronic Kidney Disease: Another Association to Worry About?

Arora, S., & Dellon, E. S. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.028 · Cited by 1 · see citing works

Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified

Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258 · see citing works

Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract—evidence from next‐generation sequencing studies

Macke, L., Schulz, C., Koletzko, L., & Malfertheiner, P. (2020) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/apt.15604 · Cited by 118 · see citing works

Pharmacomicrobiomics of Non-Antibiotic Drugs: Mechanisms and Clinical Consequences of Gut Microbiota Alterations

Dumitru, C. N., Dumitru, A. O., Goroftei, L., Niculet, E., Ignat, M. D., Baroiu, L., Nechita, A., & Balan, G. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18060651 · Cited by 4 · see citing works

Epstein-Barr virus infection and oral squamous cell carcinoma risk: A meta-analysis

She, Y., Nong, X., Zhang, M., & Wang, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186860 · Cited by 88 · see citing works

Diabetic retinopathy in Ethiopia: A systematic review and meta-analysis

Fite, R. O., Lake, E. A., & Hanfore, L. K. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.04.016 · Cited by 28 · see citing works

[Eradication of H.pylori may cause gastroesophageal reflux disease: a meta-analysis].

Xie, T., Zheng, H., & Jiang, B. (2013) · PubMed

The Prognostic Effect of Dexamethasone on Patients With Glioblastoma: A Systematic Review and Meta-Analysis

Zhou, L., Shen, Y., Huang, T., Sun, Y., Alolga, R. N., Zhang, G., & Ge, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.727707 · Cited by 28 · see citing works

Undernutrition and its determinants among Ethiopian adolescent girls: a protocol for systematic review and meta-analysis

Takele, W. W., Muche, A. A., Mekonnen, Z. A., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026718 · Cited by 3 · see citing works